State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT02659956 N/A
Recruiting
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
250 pts
Location
United States
Sponsor
National Institute of Neurolog
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
NCT01266577 N/A
Recruiting
Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging M...
Condition
Brain Mapping
Enrollment
300 pts
Location
United States
Sponsor
National Institute of Mental H
NCT03331380 N/A
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a...
Condition
CAD
Enrollment
2,950 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT05440422 Phase 2
Recruiting
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With S...
Condition
Systemic Lupus Erythematosus
Enrollment
45 pts
Location
United States
Sponsor
National Institute of Arthriti
NCT07287137 Phase 4
Recruiting
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Condition
COVID -19
Enrollment
54 pts
Location
United States
Sponsor
Henry M. Jackson Foundation fo
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07031323 N/A
Recruiting
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Condition
Cystic Fibrosis (CF)
Enrollment
60 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT03193151 N/A
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Condition
Liver Dysfunction
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT07097545 N/A
Recruiting
Change in Social Media Use and Well-being Among College Students Receiving a Two...
Condition
Social Media Addiction
Enrollment
300 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School
NCT07154823 N/A
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients ...
Condition
Acute Myeloid Leukaemia (AML)
Enrollment
550 pts
Location
United States
Sponsor
Tempus AI
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06741527 N/A
Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Condition
Rotator Cuff Tears of the Shoulder
Enrollment
150 pts
Location
United States
Sponsor
Anika Therapeutics, Inc.
NCT04927429 N/A
Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging
Condition
Cardiovascular Disease
Enrollment
3,400 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT06161545 Phase 2
Recruiting
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resect...
Condition
Stage II Squamous Cell Carcinoma of the Head and Neck
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06941857 Phase 2
Recruiting
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in...
Condition
Pancreatic Cancer
Enrollment
20 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT06289101 N/A
Recruiting
text4FATHER R21: Social Media - Efficacy Trial
Condition
Fathers
Enrollment
180 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals